Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows
First published on http://www.aidsmap.com/ on 26 Feb 2015
Christine Danel presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com
Starting HIV treatment at a CD4 cell count above 500 reduced the risk of serious illness including tuberculosis (TB), and death, by 44% when compared to starting treatment according to World Health Organization (WHO) guidelines, results from the seven-year Temprano study show. The findings were presented on Wednesday at the Conference on Retroviruses and Opportunistic Infections (CROI 2015)
in Seattle, USA.